ArticleJournal of hematology2022

Durable Remission in Hodgkin Lymphoma Treated With One Cycle of Bleomycin, Vinblastine, Dacarbazine and Two Doses of Nivolumab and Brentuximab Vedotin.

Binoy Yohannan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.